pf614
·Code: PF614
pf614: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ensysce Biosciences Inc. (ENSC) | Phase 1 |
Clinical Trials (1)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF614 for the Treatment of Moderate to Severe Pain After Abdominoplasty
Frequently asked questions
Who is developing pf614?
pf614 is being developed by Ensysce Biosciences Inc..
How many clinical trials involve pf614?
BioSniper tracks 1 clinical trial involving pf614.
Get deeper analysis on pf614
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis